{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:18:40Z","timestamp":1793146720040,"version":"4.5.0"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Platelet transfusions are critical interventions for neonates and children who are at risk of or who are experiencing bleeding.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To describe the epidemiology of platelet transfusions and associations of blood donor and platelet characteristics with posttransfusion platelet increments, transfusion burden, and clinical outcomes in neonates and children.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cohort study included patients younger than 18 years of age (with birth weights higher than 2500 g) between April 1, 2019, and June 30, 2023, from the Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric Vein-to-Vein multicenter, retrospective, donor-component-recipient\u2212linked database. Neonates were considered individuals less than 28 days of age; otherwise, participants were considered older children.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Platelet transfusion.<\/jats:p>\n <\/jats:sec>\n \n Main Outcome and Measures<\/jats:title>\n The main outcomes were posttransfusion platelet increments and subsequent transfusion burden associated with platelet processing and donor characteristics.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of 249\u202f340 inpatient encounters, platelet transfusion was reported in 8874 (3.6%) patients (4934 of 131\u202f592 encounters [3.7%] male; median [IQR] age 2.5 [0.6-11.2] years). Platelet transfusion was lowest among children younger than 1 year of age (2.6%) and highest among children 1 to less than 6 years of age (4.7%;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). The median (IQR) dose was 14.9 mL\/kg for neonates and 9.6 mL\/kg for older children. After excluding patients with bleeding, most transfusions in neonates (67.8%) and older children (81.0%) were performed at pretransfusion platelet counts greater than 25\u2009\u00d7\u200910\n 3<\/jats:sup>\n \/\u00b5L and greater than 10\u2009\u00d7\u200910\n 3<\/jats:sup>\n \/\u00b5L, respectively. Median (IQR) pretransfusion platelet counts in neonates (34\u2009\u00d7\u200910\n 3<\/jats:sup>\n \/\u00b5L [20-54\u2009\u00d7\u200910\n 3<\/jats:sup>\n \/\u00b5L]) were significantly higher than in older children (22\u2009\u00d7\u200910\n 3<\/jats:sup>\n \/\u00b5L [11-40\u2009\u00d7\u200910\n 3<\/jats:sup>\n \/\u00b5L];\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). Pathogen reduction (PR) (adjusted odds ratio [AOR], 0.82 [95% CI, 0.73-0.92]), use of platelet additive solution (PAS) (AOR, 0.32 [95% CI, 0.27-0.37]), platelet storage duration longer than 3 days (AORs ranged from 0.67 [95% CI, 0.58-0.76] to 0.82 [95% CI, 0.76-0.88]), male sex (AOR, 0.92 [95% CI, 0.86-0.98]), and donor age 40 years or older (AOR, 0.79 [95% CI, 0.72-0.86]) were associated with lower platelet increments (all\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). Use of PR platelets (adjusted rate ratio [ARR], 1.05 [95% CI, 1.02-1.07), use of PAS (ARR, 1.44 [95% CI, 1.40-1.47]), storage duration longer than 3 days (ARR, 1.11 [95% CI, 1.09-1.13] for 4 to &amp;lt;5 days and ARR, 1.28 [95% CI, 1.26-1.30] for \u22655 days), and donor age of 40 years or older (ARR, 1.15 [95% CI, 1.13-1.17] for 40 to &amp;lt;60 years and ARR, 1.10 [95% CI, 1.08-1.12] for \u226560 years) on the first transfusion were associated with a significantly higher rate of receiving a subsequent transfusion. These factors were not associated with hospital length of stay or mortality.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this multicenter, donor-product-recipient linked cohort study, after excluding patients with bleeding, most transfusions among neonates and older children were at high pretransfusion platelet counts. Use of PAS, PR, longer storage duration, male donors, and donor age older than 40 years were independently associated with lower posttransfusion platelet increments. Use of PAS, PR, platelet storage longer than 3 days, and donor age 40 years or older were associated with a significantly higher overall platelet transfusion burden but were not associated with hospital length of stay or mortality. These results have important implications for transfusion practices for platelets among neonates and children and need validation in well-designed prospective studies.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.54531","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:31:22Z","timestamp":1769617882000},"page":"e2554531","source":"Crossref","is-referenced-by-count":5,"title":["Platelet Transfusion Practices and Outcomes in Neonates and Children"],"prefix":"10.1001","volume":"9","author":[{"given":"Ruchika","family":"Goel","sequence":"first","affiliation":[{"name":"Department of Pathology, Johns Hopkins University, Baltimore, Maryland"},{"name":"Division of Hematology and Oncology, Simmons Cancer Institute at SIU School of Medicine, Springfield, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Karam","sequence":"additional","affiliation":[{"name":"Pediatric Critical Care Medicine, Department of Pediatrics, Yale, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald E.","family":"Warden","sequence":"additional","affiliation":[{"name":"Westat, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Birch","sequence":"additional","affiliation":[{"name":"Westat, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Binns","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowena","family":"Punzalan","sequence":"additional","affiliation":[{"name":"Versiti Blood Research Institute, Milwaukee, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nareg","family":"Roubinian","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Northern California Division of Research, Pleasanton, California"},{"name":"Vitalant Research Institute, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalan","family":"Yurtsever","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi M.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Emory University and Children's Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bougie","sequence":"additional","affiliation":[{"name":"Thrombosis and Hemostasis Program, Versiti Blood Research Institute, Milwaukee, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Luban","sequence":"additional","affiliation":[{"name":"Children\u2019s National Medical Center, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra D.","family":"Josephson","sequence":"additional","affiliation":[{"name":"Johns Hopkins All Children\u2019s Hospital, St Petersburg, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Sola-Visner","sequence":"additional","affiliation":[{"name":"Division of Newborn Medicine, Boston Children\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne E.","family":"Nellis","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Department of Pediatrics, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"NHLBI Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"issue":"4","key":"zoi251451r1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1542\/hpeds.2022-006832","article-title":"Epidemiology of platelet transfusions in hospitalized children: a Pediatric Hospital Information System database study.","volume":"13","author":"Lang","year":"2023","journal-title":"Hosp Pediatr"},{"issue":"8","key":"zoi251451r2","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1097\/CCM.0000000000003192","article-title":"Platelet transfusion practices in critically ill children.","volume":"46","author":"Nellis","year":"2018","journal-title":"Crit Care Med"},{"issue":"22","key":"zoi251451r3","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1182\/blood.2022018017","article-title":"How I diagnose and treat neonatal thrombocytopenia.","volume":"141","author":"Stanworth","year":"2023","journal-title":"Blood"},{"key":"zoi251451r4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1182\/asheducation.V2012.1.512.3798533","article-title":"Thrombocytopenia, bleeding, and use of platelet transfusions in sick neonates.","volume":"2012","author":"Stanworth","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"5","key":"zoi251451r5","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/bjh.14233","article-title":"Guidelines on transfusion for fetuses, neonates and older children.","volume":"175","author":"New","year":"2016","journal-title":"Br J Haematol"},{"issue":"6","key":"zoi251451r6","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/MOH.0000000000000542","article-title":"Neonatal and pediatric platelet transfusions: current concepts and controversies.","volume":"26","author":"Patel","year":"2019","journal-title":"Curr Opin Hematol"},{"issue":"8","key":"zoi251451r7","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1111\/trf.15855","article-title":"Individual- and hospital-level correlates of red blood cell, platelet, and plasma transfusions among hospitalized children and neonates: a nationally representative study in the United States.","volume":"60","author":"Goel","year":"2020","journal-title":"Transfusion"},{"issue":"3","key":"zoi251451r8","first-page":"216","article-title":"The impact of donor sex and age on stored platelet metabolism and post-transfusion recovery.","volume":"19","author":"D\u2019Alessandro","year":"2021","journal-title":"Blood Transfus"},{"issue":"4","key":"zoi251451r9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/vox.12443","article-title":"Effect of platelet storage time on platelet measurements: a systematic review and meta-analyses.","volume":"111","author":"Caram-Deelder","year":"2016","journal-title":"Vox Sang"},{"issue":"4","key":"zoi251451r10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/vox.12494","article-title":"Effect of storage time of platelet products on clinical outcomes after transfusion: a systematic review and meta-analyses.","volume":"112","author":"Kreuger","year":"2017","journal-title":"Vox Sang"},{"issue":"2","key":"zoi251451r11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/vox.12622","article-title":"Prolonged platelet storage associated with increased frequency of transfusion-related adverse events.","volume":"113","author":"Losos","year":"2018","journal-title":"Vox Sang"},{"key":"zoi251451r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2023.113666","article-title":"Neonatal thrombocytopenia: factors associated with the platelet count increment following platelet transfusion.","volume":"263","author":"Christensen","year":"2023","journal-title":"J Pediatr"},{"issue":"5","key":"zoi251451r13","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/trf.17319","article-title":"Associations between ABO non-identical platelet transfusions and patient outcomes\u2014a multicenter retrospective analysis.","volume":"63","author":"Bougie","year":"2023","journal-title":"Transfusion"},{"issue":"3","key":"zoi251451r14","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1056\/NEJMoa1807320","article-title":"Randomized trial of platelet-transfusion thresholds in neonates.","volume":"380","author":"Curley","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi251451r15","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/archdischild-2022-324915","article-title":"Two-year outcomes following a randomised platelet transfusion trial in preterm infants.","volume":"108","author":"Moore","year":"2023","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"zoi251451r16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/PCC.0000000000002102","article-title":"Platelet transfusion practice and related outcomes in pediatric extracorporeal membrane oxygenation.","volume":"21","author":"Cashen","year":"2020","journal-title":"Pediatr Crit Care Med"},{"issue":"10","key":"zoi251451r17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-039132","article-title":"Platelet transfusion for neonates with thrombocytopaenia: protocol for a systematic review.","volume":"10","author":"Liu","year":"2020","journal-title":"BMJ Open"},{"issue":"7","key":"zoi251451r18","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/PCC.0000000000003217","article-title":"Association of interventions with outcomes in children at-risk for pediatric acute respiratory distress syndrome: a pediatric acute respiratory distress syndrome incidence and epidemiology study.","volume":"24","author":"Hamill","year":"2023","journal-title":"Pediatr Crit Care Med"},{"issue":"5","key":"zoi251451r19","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/trf.16869","article-title":"The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): a research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan.","volume":"62","author":"Josephson","year":"2022","journal-title":"Transfusion"},{"issue":"9","key":"zoi251451r20","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1111\/trf.17507","article-title":"How do we build a comprehensive Vein-to-Vein (V2V) database for conduct of observational studies in transfusion medicine? demonstrated with the Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric V2V database protocol.","volume":"63","author":"Birch","year":"2023","journal-title":"Transfusion"},{"issue":"7","key":"zoi251451r21","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1111\/trf.16443","article-title":"Transfusion practices in a large cohort of hospitalized children.","volume":"61","author":"Nellis","year":"2021","journal-title":"Transfusion"},{"issue":"7","key":"zoi251451r22","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jama.2025.7529","article-title":"Platelet transfusion: 2025 AABB and ICTMG international clinical practice guidelines.","volume":"334","author":"Metcalf","year":"2025","journal-title":"JAMA"},{"issue":"10","key":"zoi251451r23","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients.","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"issue":"11","key":"zoi251451r24","doi-asserted-by":"publisher","first-page":"E305","DOI":"10.1002\/ajh.27053","article-title":"Predictors of the corrected count increment after platelet transfusion, a secondary analysis of the PACER randomized controlled trial.","volume":"98","author":"van Baarle","year":"2023","journal-title":"Am J Hematol"},{"issue":"4","key":"zoi251451r25","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/j.1537-2995.2007.01613.x","article-title":"Patient and product factors affecting platelet transfusion results.","volume":"48","author":"Heim","year":"2008","journal-title":"Transfusion"},{"issue":"1","key":"zoi251451r26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.tracli.2007.03.007","article-title":"[Factors affecting posttransfusion platelet efficiency \u201cclose relationship between patient and product\u201d].","volume":"14","author":"Senseb\u00e9","year":"2007","journal-title":"Transfus Clin Biol"},{"issue":"15","key":"zoi251451r27","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1182\/blood-2008-10-167643","article-title":"Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention.","volume":"113","author":"Vamvakas","year":"2009","journal-title":"Blood"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2844428\/goel_2026_oi_251451_1769009245.35544.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:31:23Z","timestamp":1769617883000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2844428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.54531","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]}}}